Dear Colleague,

The Global Bioproduction Summit (12 - 13 December, San Diego) agenda tells the collective stories of those building the facilities of the future. Including an exclusive case-study of Amgen's state-of-the-art biomanufacturing plant in Singapore.

Your peers share your goals of cheaper and more efficient bioprocesses which ensure quality and regulatory compliance.

And they're making serious progress.

This summit is where you'll hear the latest updates from the teams with the most to share.

The agenda features 30 high level technical presentations on hybrid facilities, continuous manufacturing, upstream, downstream and R&D from speakers such as:

• Chris Crowell Ph.D., Executive Director, Global Operations, Amgen
• Lisa A. Sykes, Director, Global Quality Operations, Merck
• Hao Chen Ph.D., Director, Upstream Process Development, Biologics & Vaccines Merck Research Laboratories
• Joseph McLaughlin, Associate Research Fellow, Bioprocess R&D, BRD Mfg, Pfizer
• James Patch, Principal Engineer, Purification Development, Genentech
• Yong Wang, Head, Early Stage BioProcess Development, Shire

The final brochure has just been released. For the full speaker line up and agenda you can download a copy here.

To secure your place at the early registration rates click here.*

The next generation of bioproduction facilities will be leaner, cleaner and more flexible. The summit will show you how to get there first.

Kind regards,

Josh

Josh Lowth
Senior Campaign Manager
Mark Allen Business
biologicalproduction.com

*Delegate places are not available to commercial service providers or those with a business development role. Please email us to find out more about sponsorship opportunities.